Global Prescription Orthopedic Drugs Market Report 2025

Prescription Orthopedic Drugs Global Market Report 2025 - By Drug Type (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Other Drug Types), By Application (Osteoarthritis, Rheumatoid Arthritis, Osteoporosis, Other Applications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Market Size, Trends, And Global Forecast 2025-2034

Prescription Orthopedic Drugs Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : March 2025 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Prescription Orthopedic Drugs Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

What Is Covered Under Prescription Orthopedic Drugs Market

Prescription orthopedic drugs refer to medications specifically prescribed to manage conditions affecting the musculoskeletal system, such as bones, joints, muscles, and ligaments. They are used for pain relief, inflammation reduction, and promoting healing in orthopedic injuries or disorders like arthritis, fractures, and tendonitis.

The main drug types of prescription orthopedic drugs are nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, corticosteroids, disease-modifying antirheumatic drugs (DMARDs), and others. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a class of medications that reduce pain, inflammation, and fever by inhibiting enzymes involved in the production of prostaglandins. These drugs are used for conditions such as osteoarthritis, rheumatoid arthritis, osteoporosis, and other related disorders. They are distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies.

How Is The Prescription Orthopedic Drugs Market Segmented?

The prescription orthopedic drugs market covered in this report is segmented –

1) By Drug Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Other Drug Types

2) By Application: Osteoarthritis, Rheumatoid Arthritis, Osteoporosis, Other Applications

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Celecoxib, Indomethacin

2) By Opioids: Morphine, Oxycodone, Hydrocodone, fentanyl, Tramadol

3) By Corticosteroids: Prednisone, Methylprednisolone, Dexamethasone, Hydrocortisone, Betamethasone

4) By Disease-Modifying Antirheumatic Drugs (DMARDs): Methotrexate, Hydroxychloroquine, Leflunomide, Sulfasalazine, Azathioprine

5) By Other Drug Types: Bisphosphonates, Calcitonin, Monoclonal Antibodies, Muscle Relaxants, Hyaluronic Acid Injections

Prescription Orthopedic Drugs Market Size and growth rate 2025 to 2029: Graph

What Is The Prescription Orthopedic Drugs Market Size 2025 And Growth Rate?

The prescription orthopedic drugs market size has grown strongly in recent years. It will grow from $48.41 billion in 2024 to $51.55 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to the rise in the prevalence of musculoskeletal disorders, the increase in the geriatric population, the growth in awareness of osteoporosis treatments, the expanding healthcare access in developing regions, and the increase in sports-related injuries worldwide.

What Is The Prescription Orthopedic Drugs Market Growth Forecast?

The prescription orthopedic drugs market size is expected to see strong growth in the next few years. It will grow to $65.32 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to growing demand for biologics, increasing geriatric population, expanding healthcare access in emerging markets, rising prevalence of chronic musculoskeletal disorders, and increasing investments in orthopedic drug research and development. Major trends in the forecast period include advancements in targeted biologics, adoption of regenerative medicine therapies, personalized drug formulations, advancements in minimally invasive delivery methods, enhanced drug efficacy through gene therapy, innovations in injectable formulations, and innovations in artificial intelligence for drug development and clinical decision-making.

What Is Driving The Prescription Orthopedic Drugs Market: Rising Prevalence Of Musculoskeletal Disorders Driving Demand For Treatment Solutions

The increasing incidence of musculoskeletal disorders is expected to drive the growth of the prescription orthopedic drugs market going forward. Musculoskeletal disorders (MSDs) are injuries and conditions that affect the movement and function of the human body's musculoskeletal system, which includes muscles, tendons, ligaments, nerves, and joints, resulting in pain and reduced mobility. The increasing incidence of musculoskeletal disorders is primarily due to factors such as aging, occupational activities involving repetitive movements and awkward postures, lifestyle choices such as physical inactivity and poor nutrition, and genetic predispositions. Prescription orthopedic drugs play a vital role in managing musculoskeletal disorders by alleviating pain, reducing inflammation, and enhancing the healing process, thereby improving mobility and overall quality of life. For instance, in March 2023, according to the Office for Health Improvement and Disparities, a UK-based government department for public health, it was reported that, in 2022, 17.6% of people aged 16 and over reported having a long-term musculoskeletal (MSK) condition, such as arthritis or ongoing back or joint problems, up from 17.0% in 2021. Moreover, in July 2022, according to the World Health Organization, a Switzerland-based intergovernmental organization, around 1.71 billion people worldwide suffer from musculoskeletal disorders. Therefore, the increasing incidence of musculoskeletal disorders is driving the growth of the prescription orthopedic drugs market.

Who Are The Major Players In The Global Prescription Orthopedic Drugs Market?

Major companies operating in the prescription orthopedic drugs market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck KGaA, AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, GSK Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Biogen Inc., UCB S.A., Allergan plc, Penardo Biotech Pvt. Ltd., Horizon Therapeutics plc

What Are The Key Trends Of The Global Prescription Orthopedic Drugs Market: Advancements In Orthopedic Drug Indications For Enhanced Surgical Pain Management

Major companies operating in the prescription orthopedic drugs market are focusing on expanding indications for their drugs to broaden their market reach, enhance patient outcomes, and address unmet medical needs in various orthopedic conditions. For instance, in January 2023, Heron Therapeutics Inc., a US-based biotechnology company, received FDA approval for the expanded use of ZYNRELEF (bupivacaine and meloxicam) in soft tissue and orthopedic procedures, including foot and ankle surgeries. This extended-release solution is uniquely designed to provide prolonged pain relief for up to 72 hours, reducing or eliminating the need for opioids after surgery. The expanded indication now covers additional orthopedic and soft tissue procedures, including foot and ankle surgeries, broadening its applicability in clinical settings. Its innovative dual-drug combination delivers both local anesthetic and anti-inflammatory effects, making it a comprehensive option for managing post-operative pain with enhanced patient outcomes.

What Are Latest Mergers And Acquisitions In The Prescription Orthopedic Drugs Market: ProMed Pharma Expands Drug Delivery Capabilities With Acquisition Of SpineThera Inc.

In April 2024, ProMed Pharma LLC, a US-based pharmaceutical company, acquired SpineThera Inc. for an undisclosed amount. With this acquisition, ProMed aims to enhance its drug delivery capabilities by leveraging SpineThera’s expertise in extended-release injectable therapies, particularly for pain management in musculoskeletal and orthopedic conditions. SpineThera Inc. is a US-based company that specializes in extended-release injectable therapies for pain management in musculoskeletal conditions, including back pain and orthopedic disorders.

What Is The Regional Outlook For The Global Prescription Orthopedic Drugs Market?

North America was the largest region in the prescription orthopedic drugs market in 2024. The regions covered in the prescription orthopedic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the prescription orthopedic drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Prescription Orthopedic Drugs  Market?

The prescription orthopedic drugs market consists of sales of products such as bisphosphonates, creams, gels, or patches, calcium and vitamin D supplements, and analgesics. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Prescription Orthopedic Drugs  Industry?

The prescription orthopedic drugs market research report is one of a series of new reports from The Business Research Company that provides prescription orthopedic drugs market statistics, including the prescription orthopedic drugs industry's global market size, regional shares, competitors with a prescription orthopedic drugs market share, detailed prescription orthopedic drugs market segments, market trends and opportunities, and any further data you may need to thrive in the prescription orthopedic drugs industry. This prescription orthopedic drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Prescription Orthopedic Drugs Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $51.55 billion
Revenue Forecast In 2034 $65.32 billion
Growth Rate CAGR of 6.1% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The prescription orthopedic drugs market covered in this report is segmented –
1) By Drug Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Other Drug Types
2) By Application: Osteoarthritis, Rheumatoid Arthritis, Osteoporosis, Other Applications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Celecoxib, Indomethacin
2) By Opioids: Morphine, Oxycodone, Hydrocodone, Fentanyl, Tramadol
3) By Corticosteroids: Prednisone, Methylprednisolone, Dexamethasone, Hydrocortisone, Betamethasone
4) By Disease-Modifying Antirheumatic Drugs (DMARDs): Methotrexate, Hydroxychloroquine, Leflunomide, Sulfasalazine, Azathioprine
5) By Other Drug Types: Bisphosphonates, Calcitonin, Monoclonal Antibodies, Muscle Relaxants, Hyaluronic Acid Injections
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck KGaA, AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, GSK Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Biogen Inc., UCB S.A., Allergan plc, Penardo Biotech Pvt. Ltd., Horizon Therapeutics plc
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Prescription Orthopedic Drugs Market Characteristics

    3. Prescription Orthopedic Drugs Market Trends And Strategies

    4. Prescription Orthopedic Drugs Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

    5. Global Prescription Orthopedic Drugs Growth Analysis And Strategic Analysis Framework

    5.1. Global Prescription Orthopedic Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Prescription Orthopedic Drugs Market Growth Rate Analysis

    5.4. Global Prescription Orthopedic Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Prescription Orthopedic Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Prescription Orthopedic Drugs Total Addressable Market (TAM)

    6. Prescription Orthopedic Drugs Market Segmentation

    6.1. Global Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

    Opioids

    Corticosteroids

    Disease-Modifying Antirheumatic Drugs (DMARDs)

    Other Drug Types

    6.2. Global Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Osteoarthritis

    Rheumatoid Arthritis

    Osteoporosis

    Other Applications

    6.3. Global Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies

    Online Pharmacies

    Other Distribution Channels

    6.4. Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Ibuprofen

    Naproxen

    Diclofenac

    Celecoxib

    Indomethacin

    6.5. Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Opioids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Morphine

    Oxycodone

    Hydrocodone

    Fentanyl

    Tramadol

    6.6. Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Prednisone

    Methylprednisolone

    Dexamethasone

    Hydrocortisone

    Betamethasone

    6.7. Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Disease-Modifying Antirheumatic Drugs (DMARDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Methotrexate

    Hydroxychloroquine

    Leflunomide

    Sulfasalazine

    Azathioprine

    6.8. Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Bisphosphonates

    Calcitonin

    Monoclonal Antibodies

    Muscle Relaxants

    Hyaluronic Acid Injections

    7. Prescription Orthopedic Drugs Market Regional And Country Analysis

    7.1. Global Prescription Orthopedic Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Prescription Orthopedic Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Prescription Orthopedic Drugs Market

    8.1. Asia-Pacific Prescription Orthopedic Drugs Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Prescription Orthopedic Drugs Market

    9.1. China Prescription Orthopedic Drugs Market Overview

    9.2. China Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Prescription Orthopedic Drugs Market

    10.1. India Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Prescription Orthopedic Drugs Market

    11.1. Japan Prescription Orthopedic Drugs Market Overview

    11.2. Japan Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Prescription Orthopedic Drugs Market

    12.1. Australia Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Prescription Orthopedic Drugs Market

    13.1. Indonesia Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Prescription Orthopedic Drugs Market

    14.1. South Korea Prescription Orthopedic Drugs Market Overview

    14.2. South Korea Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Prescription Orthopedic Drugs Market

    15.1. Western Europe Prescription Orthopedic Drugs Market Overview

    15.2. Western Europe Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Prescription Orthopedic Drugs Market

    16.1. UK Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Prescription Orthopedic Drugs Market

    17.1. Germany Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Prescription Orthopedic Drugs Market

    18.1. France Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Prescription Orthopedic Drugs Market

    19.1. Italy Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Prescription Orthopedic Drugs Market

    20.1. Spain Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Prescription Orthopedic Drugs Market

    21.1. Eastern Europe Prescription Orthopedic Drugs Market Overview

    21.2. Eastern Europe Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Prescription Orthopedic Drugs Market

    22.1. Russia Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Prescription Orthopedic Drugs Market

    23.1. North America Prescription Orthopedic Drugs Market Overview

    23.2. North America Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Prescription Orthopedic Drugs Market

    24.1. USA Prescription Orthopedic Drugs Market Overview

    24.2. USA Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Prescription Orthopedic Drugs Market

    25.1. Canada Prescription Orthopedic Drugs Market Overview

    25.2. Canada Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Prescription Orthopedic Drugs Market

    26.1. South America Prescription Orthopedic Drugs Market Overview

    26.2. South America Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Prescription Orthopedic Drugs Market

    27.1. Brazil Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Prescription Orthopedic Drugs Market

    28.1. Middle East Prescription Orthopedic Drugs Market Overview

    28.2. Middle East Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Prescription Orthopedic Drugs Market

    29.1. Africa Prescription Orthopedic Drugs Market Overview

    29.2. Africa Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Prescription Orthopedic Drugs Market Competitive Landscape And Company Profiles

    30.1. Prescription Orthopedic Drugs Market Competitive Landscape

    30.2. Prescription Orthopedic Drugs Market Company Profiles

    30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

    31. Prescription Orthopedic Drugs Market Other Major And Innovative Companies

    31.1. Bayer AG

    31.2. Sanofi S.A.

    31.3. Bristol-Myers Squibb Company

    31.4. AstraZeneca plc

    31.5. GSK Plc

    31.6. Takeda Pharmaceutical Company Limited

    31.7. Eli Lilly and Company

    31.8. Amgen Inc.

    31.9. Teva Pharmaceutical Industries Ltd.

    31.10. Mylan N.V.

    31.11. Biogen Inc.

    31.12. UCB S.A.

    31.13. Allergan plc

    31.14. Penardo Biotech Pvt. Ltd.

    31.15. Horizon Therapeutics plc

    32. Global Prescription Orthopedic Drugs Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Prescription Orthopedic Drugs Market

    34. Recent Developments In The Prescription Orthopedic Drugs Market

    35. Prescription Orthopedic Drugs Market High Potential Countries, Segments and Strategies

    35.1 Prescription Orthopedic Drugs Market In 2029 - Countries Offering Most New Opportunities

    35.2 Prescription Orthopedic Drugs Market In 2029 - Segments Offering Most New Opportunities

    35.3 Prescription Orthopedic Drugs Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Opioids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Disease-Modifying Antirheumatic Drugs (DMARDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Prescription Orthopedic Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Prescription Orthopedic Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Pfizer Inc. Financial Performance
  • Table 80: Johnson & Johnson Financial Performance
  • Table 81: Roche Holding AG Financial Performance
  • Table 82: Merck KGaA Financial Performance
  • Table 83: AbbVie Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Opioids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Disease-Modifying Antirheumatic Drugs (DMARDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Prescription Orthopedic Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Prescription Orthopedic Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Pfizer Inc. Financial Performance
  • Figure 80: Johnson & Johnson Financial Performance
  • Figure 81: Roche Holding AG Financial Performance
  • Figure 82: Merck KGaA Financial Performance
  • Figure 83: AbbVie Inc. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Prescription Orthopedic Drugs market?

Prescription orthopedic drugs refer to medications specifically prescribed to manage conditions affecting the musculoskeletal system, such as bones, joints, muscles, and ligaments. They are used for pain relief, inflammation reduction, and promoting healing in orthopedic injuries or disorders like arthritis, fractures, and tendonitis. For further insights on the Prescription Orthopedic Drugs market, request a sample here

How will the Prescription Orthopedic Drugs market drivers and restraints affect the market dynamics? What forces will shape the Prescription Orthopedic Drugs industry going forward?

The Prescription Orthopedic Drugs market major growth driver - Rising Prevalence Of Musculoskeletal Disorders Driving Demand For Treatment Solutions. For further insights on the Prescription Orthopedic Drugs market, request a sample here

What is the forecast market size or the forecast market value of the Prescription Orthopedic Drugs market?

The Prescription Orthopedic Drugs market size has grown strongly in recent years. The prescription orthopedic drugs market size has grown strongly in recent years. It will grow from $48.41 billion in 2024 to $51.55 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to the rise in the prevalence of musculoskeletal disorders, the increase in the geriatric population, the growth in awareness of osteoporosis treatments, the expanding healthcare access in developing regions, and the increase in sports-related injuries worldwide. The prescription orthopedic drugs market size is expected to see strong growth in the next few years. It will grow to $65.32 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to growing demand for biologics, increasing geriatric population, expanding healthcare access in emerging markets, rising prevalence of chronic musculoskeletal disorders, and increasing investments in orthopedic drug research and development. Major trends in the forecast period include advancements in targeted biologics, adoption of regenerative medicine therapies, personalized drug formulations, advancements in minimally invasive delivery methods, enhanced drug efficacy through gene therapy, innovations in injectable formulations, and innovations in artificial intelligence for drug development and clinical decision-making. For further insights on the Prescription Orthopedic Drugs market, request a sample here

How is the Prescription Orthopedic Drugs market segmented?

The prescription orthopedic drugs market covered in this report is segmented –
1) By Drug Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Other Drug Types
2) By Application: Osteoarthritis, Rheumatoid Arthritis, Osteoporosis, Other Applications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Celecoxib, Indomethacin
2) By Opioids: Morphine, Oxycodone, Hydrocodone, Fentanyl, Tramadol
3) By Corticosteroids: Prednisone, Methylprednisolone, Dexamethasone, Hydrocortisone, Betamethasone
4) By Disease-Modifying Antirheumatic Drugs (DMARDs): Methotrexate, Hydroxychloroquine, Leflunomide, Sulfasalazine, Azathioprine
5) By Other Drug Types: Bisphosphonates, Calcitonin, Monoclonal Antibodies, Muscle Relaxants, Hyaluronic Acid Injections For further insights on the Prescription Orthopedic Drugs market,
request a sample here

Which region has the largest share of the Prescription Orthopedic Drugs market? What are the other regions covered in the report?

North America was the largest region in the prescription orthopedic drugs market in 2024. The regions covered in the prescription orthopedic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Prescription Orthopedic Drugs market, request a sample here.

Who are the major players in the Prescription Orthopedic Drugs market?

Major companies operating in the prescription orthopedic drugs market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck KGaA, AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, GSK Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Biogen Inc., UCB S.A., Allergan plc, Penardo Biotech Pvt. Ltd., Horizon Therapeutics plc . For further insights on the Prescription Orthopedic Drugs market, request a sample here.

What are the key trends in the Prescription Orthopedic Drugs market?

Major trends in the Prescription Orthopedic Drugs market include Advancements In Orthopedic Drug Indications For Enhanced Surgical Pain Management. For further insights on the Prescription Orthopedic Drugs market, request a sample here.

What are the major opportunities in the Prescription Orthopedic Drugs market? What are the strategies for the Prescription Orthopedic Drugs market?

For detailed insights on the major opportunities and strategies in the Prescription Orthopedic Drugs market, request a sample here.

How does the Prescription Orthopedic Drugs market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Prescription Orthopedic Drugs market growth and SWOT analysis of the Prescription Orthopedic Drugs industry, request a sample here.

For detailed insights on Prescription Orthopedic Drugs's relation to the overall economy and other similar markets,

What are the latest mergers and acquisitions in the Prescription Orthopedic Drugs industry? request a sample here.

For detailed insights on the mergers and acquisitions in the Prescription Orthopedic Drugs industry,

What are the key dynamics influencing the Prescription Orthopedic Drugs market growth? SWOT analysis of the Prescription Orthopedic Drugs market. request a sample here.